temozolomide has been researched along with Solitary Fibrous Tumors in 4 studies
Solitary Fibrous Tumors: Rare neoplasms of mesenchymal origin, usually benign, and most commonly involving the PLEURA (see SOLITARY FIBROUS TUMOR, PLEURAL). They also are found in extrapleural sites.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cases from June 2006 through October 2016 were identified for patients receiving bevacizumab and temozolomide for locally advanced, recurrent or metastatic solitary fibrous tumour or hemangiopericytoma, which is sometimes used to describe tumours arising from the meninges." | 3.91 | Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis. ( de Lemos, ML; Kang, I; Schaff, K, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeda, O | 1 |
| Ohka, F | 1 |
| Maesawa, S | 1 |
| Matsuoka, A | 1 |
| Shimokata, T | 1 |
| Mitsuma, A | 1 |
| Urakawa, H | 1 |
| Nakamura, S | 1 |
| Shimoyama, Y | 1 |
| Nakaguro, M | 1 |
| Wakabayashi, T | 1 |
| Ando, Y | 1 |
| de Lemos, ML | 1 |
| Kang, I | 1 |
| Schaff, K | 1 |
| Stacchiotti, S | 1 |
| Tortoreto, M | 1 |
| Bozzi, F | 1 |
| Tamborini, E | 1 |
| Morosi, C | 1 |
| Messina, A | 1 |
| Libertini, M | 1 |
| Palassini, E | 1 |
| Cominetti, D | 1 |
| Negri, T | 1 |
| Gronchi, A | 1 |
| Pilotti, S | 1 |
| Zaffaroni, N | 1 |
| Casali, PG | 1 |
| Park, MS | 1 |
| Patel, SR | 1 |
| Ludwig, JA | 1 |
| Trent, JC | 1 |
| Conrad, CA | 1 |
| Lazar, AJ | 1 |
| Wang, WL | 1 |
| Boonsirikamchai, P | 1 |
| Choi, H | 1 |
| Wang, X | 1 |
| Benjamin, RS | 1 |
| Araujo, DM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Solitary Fibrous Tumor: Phase II Study on Trabectedin Versus Adriamycin Plus Dacarbazine in Advanced Patients[NCT03023124] | Phase 2 | 50 participants (Anticipated) | Interventional | 2018-03-04 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for temozolomide and Solitary Fibrous Tumors
| Article | Year |
|---|---|
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review.
Topics: Antineoplastic Agents, Immunological; Bevacizumab; Drug-Related Side Effects and Adverse Reactions; | 2020 |
Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Hemangiopericytoma | 2019 |
Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics.
Topics: Adult; Aged; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protoc | 2013 |
Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Beva | 2011 |